Resveratrol treatment for Acanthamoeba eye infections
Part of Eyes & vision, Infections clinical trials.
This study tests a natural compound called resveratrol (and a nanoparticle version) as a possible treatment for Acanthamoeba eye infections, which cause painful corneal ulcers. If you have this type of infection, the treatment might help heal your eye.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have keratitis (inflammation of the cornea) or a corneal ulcer (a sore on the clear front part of your eye).
- Your condition is caused by Acanthamoeba, not by bacteria, viruses, or fungi.
- You do not have other eye problems like a corneal perforation, severe dry eye, glaucoma, scleritis, or active uveitis.
- You have not had any previous eye surgery or a corneal transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment for people who still have eye inflammation after 1 month of standard treatment for a parasitic eye infection (acanthamoeba keratitis). It aims to find a better way to control the infection and reduce inflammation.
This Phase 2 trial tests a locally delivered cell-based treatment (allogeneic mesenchymal stromal cells) to help heal long-lasting damage to the eye’s clear surface (the cornea). It may help if your cornea epithelium (surface layer) won’t improve even after standard non-surgical treatments.
This trial tests a new eye drop (acoltrepon) to see if it helps people with stage 1 neurotrophic keratopathy (a condition where the cornea's nerves are damaged, causing dry eyes and vision problems) and low tear production. It aims to improve signs like corneal staining and symptoms of discomfort.
This trial tests if adding cyclosporine A to the standard natamycin eye drops can better treat fungal eye infections. It may help people with moderate vision loss from a fungal corneal infection.
This study tests a new medication called Acoltremon to see if it helps dry eye symptoms over a long period. If you've had dry eye for a while and used artificial tears, this trial might be for you.
This Phase 2 study tests whether eye drops containing a medicine called N-acetylcysteine (NAC) can reduce damaging “reactive oxygen” in people with advanced Fuchs’ endothelial corneal dystrophy (FECD). It involves people who need a special cornea transplant (DMEK) at the same time as cataract surgery, aiming to improve cornea healing and vision.
Hear when a new Corneal Ulcer Caused by Acanthamoeba trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.